Skip to main content

Table 1 Clinical and demographic characteristics of patients

From: Comparison of nutritional screening tools to assess nutritional risk and predict clinical outcomes in Mexican patients with digestive diseases

 

Y/N

Total

Morbidity

Student’s t test p-value

Mortality

Student’s t test p-value

Age (years)

Yes

46.4 ± 16.7

48 ± 17.3

52.3 ± 15.1

No

45.6 ± 16.5

46.1 ± 16.8

LOS (days)

Yes

5.5 ± 4.6

9.1 ± 5.9

<0.001

9 ± 3.7

0.009

No

3.6 ± 2.1

5.36 ± 4.6

NComp

Yes

0.5 ± 0.8

2.5 ± 1.3

<0.001

No

0.41 ± 0.68

BMI (kg/m2)

Yes

26.9 ± 7.6

25.7 ± 4.9

0.001

25.05 ± 2.7

0.005

No

28.1 ± 8.6

27.05 ± 7.9

Cholesterol (mg/dL)

Yes

157.1 ± 128.2

137.4 ± 73.7

79.8 ± 30.8

0.031

No

167.6 ± 148.4

162.1± 130.5

LCount (103/ml)

Yes

1586.08 ± 992.6

1377.1 ± 846.7

0.007

1188.3 ± 423.9

No

1770.4 ± 1008.3

1663.06 ± 990.4

Albumin (mg/dL)

Yes

3.3 ± 0.7

2.9 ± 0.8

<0.001

2.8 ± 0.5

0.023

No

3.4 ± 0.68

3.3 ± 0.79

Weight (kg)

Yes

71.2 ± 20.6

65.2 ± 13.8

0.001

67.5 ± 7.5

< 0.001

No

74.3 ± 22.9

71.4 ± 21.2

% WL 6m

Yes

7.4 ± 8.4

8.2 ± 9.3

8.2 ± 4.3

No

7.01 ± 7.8

7.3 ± 8.6

% WL 2wk

Yes

4.7 ± 4.6

5.8 ± 5.9

0.034

5.1 ± 3

No

4.1 ± 3.7

4.7± 4.7

  1. Abbreviations: BMI body mass index, LOS length of hospital stay, NComp number of complications, LCount Lymphocyte count, % WL 6m percentage of weight loss in the previous 6 months, % WL 2wk percentage of weight loss in the previous 2 weeks